Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly twofold, with females more likely than males to report feeling either ...